mikeelogan's soup

SciClone Pharmaceuticals and Theravance Biopharma Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China - Yahoo Finance

Related Tweets by @WESH Photos of 16-year-old Noah Meyers show sores on his face, a condition his parents said was diagnosed as MRSA, a highly contagious staph infection. Noahs father, Billy Meyers, said at first the sores looked like pimples, but before Saturdays football game ended he has sores on his face, head and chin. "As soon as the doctor walked in, he knew immediately what it was. (He) said he never seen an infection in the face so bad, Billy Meyers said. Look at the marks. You can see where they are. They are nowhere else.
For the original version including any supplementary images or video, visit http://www.wesh.com/news/brevard-county-parents-claim-son-contracted-mrsa-from-football-helmet/33154310

Theravance Biopharma and SciClone Pharmaceuticals Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China - Yahoo Finance

About 94 percent of the U.S. shrimp supply is imported, and the majority of it is farmed. "Farming can be done responsibly, but when it's not, bacteria and disease can thrive. Antibiotics may seem like a fix, but we don't think so, and they're illegal for use in imported shrimp," said Urvashi Rangan, Ph.D., the director of Consumer Reports' Food Safety and Sustainability Center. Scientists analyzed 342 packages of frozen shrimp, farmed and wild, raw and cooked. The shrimp was purchased in supermarkets in 27 cities across the country. Overall, 60 percent of the raw shrimp samples tested positive for bacteria, so safe preparation is very important. And 11 samples, or about five percent of imported, raw, farmed shrimp, had antibiotic residues.
For the original version including any supplementary images or video, visit http://abc7.com/food/consumer-reports-finds-harmful-bacteria-in-frozen-shrimp/741368/

The New Global Strategy to Counter Drug-Resistant Microbes

If not already pregnant, women of childbearing potential should use effective contraception during VIBATIV treatment. Contraindication Intravenous unfractionated heparin sodium is contraindicated with VIBATIV administration due to artificially prolonged activated partial thromboplastin time (aPTT) test results for up to 18 hours after VIBATIV administration. VIBATIV is contraindicated in patients with a known hypersensitivity to the drug.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/sciclone-pharmaceuticals-theravance-biopharma-enter-120500246.html

Consumer Reports finds harmful bacteria in frozen shrimp | abc7.com

The results showed no detectable levels of bacteria in either pool. We apologize for the inconvenience these closures have caused, but our foremost goal was to ensure the continued health and safety of our swim community, the county wrote in the release. Staph bacteria can commonly be found on human carriers of mrsa skin, even for healthy people. Infections can turn deadly if they get into the blood, bones or organs.
For the original version including any supplementary images or video, visit http://www.reviewjournal.com/news/las-vegas/vegas-public-pools-negative-staph-mrsa

Mother claims son contracted MRSA from HS football helmet | www.wftv.com

Its an arms race, and were not winning . Countering that resistance could require more expensive drugs, which puts a strain on patients and the healthcare system as a whole. The bacteria that causes tuberculosis has also evolved to resist many drugs, and in 2013, WHO reported 480,000 new cases of multidrug-resistant TB around the world.
For the original version including any supplementary images or video, visit http://gizmodo.com/the-new-global-strategy-to-counter-antimicrobial-resist-1706944735

Nicole Meyers said on Facebook, "My son started spring football practice at Merritt Island High School. He has since contracted MRSA from wearing a football helmet that was not properly sanitized before reissue." It's something other athletes are trying to wrap their heads around. "I just hope that no one else catches it. Me personally, I feel like they should have been more precautious about this kind of stuff. I feel like they should have done, been prepared for this stuff.
For the original version including any supplementary images or video, visit http://www.wftv.com/news/news/local/mother-claims-son-contracted-mrsa-hs-football-helm/nmLp3/

Vegas public pools negative for staph, MRSA | Las Vegas pregnancy and mrsa Review-Journal

In exchange, Theravance Biopharma will be eligible to receive upfront and regulatory milestone payments totaling $6 million. SciClone will be responsible for all aspects of development and commercialization in the partnered regions, including pre- and post-launch activities and product registration. Theravance Biopharma will sell to SciClone all clinical and commercial product required to develop and commercialize VIBATIV in China. "Partnering with SciClone and expanding into the large and growing China market is a key component of Theravance Biopharma's strategy to leverage regional partners to broaden our commercial reach and establish VIBATIV as a valuable global brand," said Frank Pasqualone, Senior Vice President, Development and Operations at Theravance Biopharma."Our companies share the belief that VIBATIV can play a significant role in combating difficult-to-treat infections. SciClone's proven experience and expertise in navigating the complex regulatory and commercial landscape in China provide us confidence in their ability to obtain regulatory approval of VIBATIV in China and maximize the value of VIBATIV in its licensed regions." "We believe that VIBATIV is a very valuable addition to our portfolio of high quality, differentiated products, and targets a key, under-appreciated public health concern in China, namely the high level of antibiotic resistance," said Friedhelm Blobel, PhD, Chief Executive Officer of SciClone. "We believe that its many attractive product attributes, including its dual mechanism of action, bactericidal activity and well documented evidence of in vitro potency against a broad collection of difficult-to-treat and multi-drug resistant Gram-positive clinical pathogens, including MRSA, can establish VIBATIV as a valuable asset in the antibacterial armamentarium in China for multiple infection types.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/theravance-biopharma-sciclone-pharmaceuticals-enter-120500612.html